Pharmaceutical law regulation of research, development, and marketing editor-in-chief, Michael E. Clark.
Detalles de publicación: Arlington, Va Bureau of National Affairs c2007.Descripción: xlvi, 853 p. 26 cmISBN:- 9781570185762 (alk. paper)
- 157018576X (alk. paper)
- KF 2915 .P4 P495 2007
| Imagen de cubierta | Tipo de ítem | Biblioteca actual | Biblioteca de origen | Colección | Ubicación en estantería | Signatura topográfica | Materiales especificados | Info Vol | URL | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | Reserva de ítems | Prioridad de la cola de reserva de ejemplar | Reservas para cursos | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Libro | Biblioteca de Derecho Mons. Fremiot Torres Oliver Colección General biblioteca derecho | KF 2915 .P4 P495 2007 (Navegar estantería(Abre debajo)) | Disponible | 70000000848452 | ||||||||||||||
| Libro | Biblioteca de Derecho Mons. Fremiot Torres Oliver Colección General biblioteca derecho | KF 2915 .P4 P495 2007 (Navegar estantería(Abre debajo)) | 2008 supp | Disponible | 70000000000supp |
"American Bar Association, Health Law Section"
Includes bibliographical references and index.
Statutory and regulatory controls for drug development -- Key federal agencies regulating pharmaceuticals -- Federal regulation of advertising, promotion, and distribution practices -- Potential liability for drug companies, health care providers and insurers: off-label prescribing and internet advertising -- Federal regulation of clinical research -- Avoiding fraud and abuse penalties and sanctions -- Regulation of privacy under hipaa and other privacy laws -- Federal sentencing guidelines and compliance measures -- The FDA approval process for new drugs -- State regulatory schemes for pharmaceuticals and related issues -- Antitrust and intellectual law issues for pharmaceutical companies -- Securities law issues and disclosure considerations for pharmaceutical companies.